Information on the target
BIOLASE, Inc. (“BIOLASE” or the “Company”), founded in 1984 and headquartered in Foothill Ranch, California, is a leading developer and manufacturer of laser systems specifically designed for dental applications. The Company specializes in producing proprietary laser systems that facilitate a wide range of minimally invasive dental procedures, catering to both all-tissue and soft-tissue needs. With a strong global presence, BIOLASE has successfully sold over 47,700 laser systems across more than 80 countries, establishing itself as a recognized leader in the dental laser industry.
In light of financial challenges, BIOLASE retained SSG Capital Advisors, LLC (“SSG”) in August 2024 to explore strategic alternatives, including a potential sale of the business. To maintain operational liquidity, the Company filed for Chapter 11 protection on October 1, 2024, initiating a structured process to facilitate the sale of its assets.
Industry overview in the target’s specific country
The dental laser industry in the United States has experienced significant growth over the past few years, driven by advancements in technology and an increasing demand for minimally invasive procedures. Dental professionals are increasingly adopting laser systems due to their ability to enhance precision, reduce patient discomfort, and improve overall treatment outcomes. This trend is further supported by a growing awareness among patients regarding the benefits of laser dentistry, which has led to a rise in patient inquiries and acceptance of laser-based treatments.
Moreover, the U.S. dental market is characterized by a competitive landscape, with several key players vying for market share. The presence of established companies, such as BIOLASE, alongside emerging startups, has fostered innovation and continuous improvement in product offerings. As a result, dental practitioners are presented with a diverse range of options, enabling them to select the most suitable technologies for their practices.
Regulatory support and favorable reimbursement policies have also contributed to the industry's growth. The American Dental Association and other professional organizations have endorsed the use of laser technology in dentistry, further legitimizing its application and encouraging practitioners to invest in advanced equipment. As the market continues to evolve, the demand for high-quality, reliable dental laser systems is expected to remain robust, providing a favorable environment for companies like BIOLASE.
The rationale behind the deal The sale of BIOLASE’s assets to MegaGen Implant Co., Ltd. represents a strategic move to preserve the Company’s operations and maximize stakeholder value amid financial distress. By engaging in a Chapter 11 Section 363 process, BIOLASE was able to attract multiple bidders, u…